<< Вернуться к списку статей журнала

Том 2 №1,2 2000 год - Нефрология и диализ

Паратиреоидный гормон - универсальный уремический токсин (Обзор литературы)

Волгина Г.В. Перепеченных Ю.В.

Аннотация: О костных осложнениях, развивающихся при уремии, было известно более 100 лет назад [3, 15, 39]. На сегодняшний день отмечено, что помимо патологических изменений скелета, объединяемых в понятие ренальной остеодистрофии, нарушения кальциево-фосфорного обмена при хронической почечной недостаточности (ХПН) ведут к патологии многих других органов.

Для цитирования: Волгина Г.В., Перепеченных Ю.В. Паратиреоидный гормон - универсальный уремический токсин (Обзор литературы). Нефрология и диализ. 2000. 2(1,2):32-38. doi:

Весь текст

Ключевые слова: ХПН, паратиреоидный гормон, вторичный гиперпаратиреоидизм

Список литературы:

1. Барабанова Т.А., Пенчук Н.А. Миокард, паратиреоидный гормон и хроническая почечная недостаточность. Нефрология, 1998; 2; 2: 88-94.
2. Михайлов В.В. Патологическая физиология (общая физиология, обмен веществ). М., Изд. ММСИ, 1989;.32-36.
3. Ермоленко В.М. Нарушение фосфорно-кальциевого обмена. Нефрология. Руководство для врачей, 1995; 1; 106-125.
4. Розен В.Б. Основы эндокринологии. М., Изд. МГУ, 1994; 384.
5. Франке Ю., Рунге Г. Остеопороз (перевод с нем.). М., Медицина, 1995; 304.
6. Akizawa T., Fukagawa H., Koshikawa S., Kurosawa K. Recent progress in management secondary hyperparathyroidism of chronic renal failure. Curr Opin Hypertens 1993; 2; 558-565.
7. Akmal S.U., Massry S.G., Goldstcin D.A. et al. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 1985; 75: 1037-1044.
8. Alexiewicz J.M., Klinger M., Pitt S.M. et al. PTH inhibits B cell proliferation: implication in chronic renal failure. J Am Soc Nephrol 1990; 1: 236-244.
9. Amann K., Ritz E., Wiest G., Klaus G., Mall G. A role of parathyroid hormone for activation of cardiac fibroblast in uremia. J Amer Soc Nephrol 1994; 4(10): 1814-1819.
10. Baron J., Winer K.K., Janovski J.A. et al. Mutations of the Ca2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Human Mol Genet 1996; 5: 601-606.
11. Bellorin-Font E., Martin K.J., Feitag J.J. et al. Altered adenylate cyclase kinetics in hyperfunctioning human parathyroid glands. Comparison with normal human and bovine parathiroid tissue. J Clin Endocardiol Metab 1981; 52: 466-507.
12. Brown E.M., Pollak M., Riccardi D., Hebert S.C. Cloning and characterization of an extracellular Ca-sensing receptor from parathyroid and kidney: new insights into the physiology and pathophysiology of calcium metabolism. Nephrol Dial Transplant 1994; 9: 1703-1706.
13. Brown A.J., Ritter C., Fineh J., Slatopolsky E. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int 1999; 55: 1284-1292.
14. Cholst I.N., Steinberg S.F., Tropper P.J. et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone in human subjects. N Engl J Med 1984; 310: 1221-1225.
15. Coburn J.W., Slatopolsky E. Vitamin D, parathyroid hormone and the renal osteodystrophies in the kidney (4 th ed), edited by Brenner B.M., Rector F.C. Philadelphia, W.B.Saunders Company, 1991; 2036-2120.
16. Combe C., Aparicio M. Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 1994; 46: 1381-1386.
17. De Fronzo R.A., Alvestrand A., Smith D. et al. Insulin resistence in uremia. J Clin Invest 1981; 67: 563-568.
18. Doherty C.C., LaBelle P., Collins J.F. et al. Effect of parathyroid hormone on random migration of human polymorphonuclear leucocytes. Am J Nephrol 1988; 8: 212-219.
19. Delmez J.A., Tindira C., Groom S.P. et al. Parathyroid hormone suppression by intravenous 1,25(OH)2D3. A role for increased sensitivity to calcium. J Clin Invest 1989; 83: 1349-1355.
20. Demay M.B., Kiernan M.S., Deluca H.F. et al. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1992; 89: 8097-8101.
21. Ellis R.E., Juan J., Horwitz H.R. Mechanism and function of cell death. Ann Rev Cell Biol 1991; 7: 663-698.
22. Fadda G.Z., Hajjar S.M., Perna A.F. et al. On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 1991; 87: 255-261.
23. Falchetti A., Pale A.F., Amorosi A. Progression of uremic hyperparathyroidism involves alleic loss on chromosome 11. J Endocrinol Metab 1993; 76: 139-144.
24. Feinfeld D.A., Sherwood L.M. Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure. Kidney Int 1988; 33: 1048-1058.
25. Fensenfeld A.J., Llach F. Parathyroid gland function in chronic renal failure. Kidney Int 1993; 43: 771-789.
26. Fernandez-Reyes M.J., Auxiladora Bajo M., Robles P. et al. Mitral annular calcification in CAPD patients with a low degree of HPT. An analysis of other possible risk factors. Nephrol Dial Transplant 1995; 10: 2090-2095.
27. Fukagawa M. Resistance of parathyroid cell to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 1995; 2: 316-319.
28. Fukagawa M., Ji M., Kurokawa K. Calcitriol-induce apoptosis of hyperplastic parathyroid cells in uremic rats. J Am Soc Nephrol 1991; 2: 635 (abstract).
29. Fukuda N. Decreased 1,25 dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443.
30. Gogusev H., Duchambon P., Hory B. et al. Depressed expression of calcium receptor in parathyroid gland tissue of patient with hyperparathyroidism. Kidney Int 1997; 51: 328-336.
31. Graciong Z., Alexiewicz J.M., Lincer-Israeli M. et al. Inhibition of immunoglobulin production by PTH: implications in chronic renal failure. Kidney Int 1991; 40: 96-106.
32. Hercz G., Pei G., Greenwood C. et al. Aplastic osteodistrophy without aluminium. The role of «supressed» parathyroid function. Kidney Int 1993; 44: 860-866.
33. Islam A., Smogerzewski M., Massry S.G. Effect of verapamil of CRF-induced abnormalities in phospholipid contents of brain synaptosomes. Proc Soc Exp Biol Med 1990; 194: 16-20.
34. Juppner H., Abou Samra A., Freeman M. A G-proteinlinked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991; 254: 1024-1026.
35. Kiersztein M., Smogorzewski M., Thanakitchary P. et al. Decreased O2 consumption by PMNL from humans and rats with chronic renal failure: role of secondary hyperparathyroidism. Kidney Int 1992; 42: 602-609.
36. Kifor O., Moore F.D., Wang P. et al. Reduced immunostandartaining for the extracellular Ca sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 1598-1606.
37. Klin M., Smogorzewski M., Ni Z. et al. Abnormalites in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J Clin Invest 1996; 97: 2167-2173.
38. Korcor A.B. Reduced binding of [3H] 1,25(OH)2D3 in the parathyroid glands of patient with renal failure. N England J Med 1987; 316: 1573-1577.
39. Kurdawa K. The kidney and calcium homeostasis. Kidney Int 45(suppl.44),1994; 97-105.
40. Lacour B., Roullet J.B., Liagre A.M. et al. Serum lipoprotein disturbance in primary and secondary hyperparathyroidism and effect of parathyroidectomy. Am J Kidney Dis 8; 1986; 422-429.
41. Llach F., Massry S.G., Singer F.R. Skeletal resistence of endogenus PTH in patients with early renal failure. A possible cause of secondary hyperparathyroidism. J Clin Endocrinol Metab 1975; 44: 1054-1058.
42. London G.M., Drueke T.B. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997; 51: 1678-1695.
43. Lopex-Hilker S., Dusso A.S., Rapp N.S. et al. Phosphorus restriction reverses secondary hyperparathyroidism independent of changes in Ca2+ and calcitriol. Am J Physiol 1990; 259: 432-437.
44. Malda S., Wu S., Green J. et al. The N-terminal portion of parathyroid release peptide mediates the inhibition of apical Na+-H+-exchange in oppossum kidney cells. J Am Soc Nephrol 9; 1998; 175-181.
45. Massry S.G. Is parathyroid hormone a uremic toxin? Nephron 1977; 19: 125-130.
46. Massry S.G. The toxic effect of parathyroid hormone in uremia. Semin Nephrol 1983; 3: 306-328.
47. Massry S.G., Smogorzewski M. Mechanism through which PTH mediates its deleterious effects on organ function in uremia. Semin Nephrol 1994; 14: 219-231.
48. Massry S.G. PTH and myocardiopathy. Contrib Nephrol 1984; 41: 231-239.
49. Massry S.G., Smogorzewski M. The mechanisms responsible for the PTH induced rise in cytosolic calcium in various cells are not uniform. Miner Electrolyte Metab 1982; 7: 151-156.
50. Massry S.G., Shaefer R.M., Teschner M. et al. Effect of parathyroid hormone on elastase release from human polymorphonuclear leucocytes. Kidney Int 1989; 36: 883-890.
51. Massry S.G., Alexiewicz J.M., Gaciong Z., Klinger M. Secondary hyperparathyroidism and the immune system in CRF. Semin Nephrol 1991; 11: 186-201.
52. Nygren P., Larsson S., Rastad J., Akerstrom G. 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional differenciation of cultured bovine parathyroid cells. Calcif Tissue Int 1988; 12: 213-218.
53. Naveh-Many T., Marx R., Keshet E. et al. Regulation of 1,25(OH)2D3 receptor gene expression by 1,25(OH)2D3 in the parathyroid in vivo. J Clin Invest 86: 1968-1975, 1990
54. Ongino K., Burkhoff D., Bole Zikian J.P. The hemodynamic basis for the effects of PTH and PTHrP. Endocrinology 1995; 136: 3024-3030.
55. Parfrey P.S., Harnett J.D., Barre P.E. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 1991; 2: 2-12.
56. Park C.W., Oh Y.S., Shin Y.S. et al. Intravenous calcitriol regress myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Amer J Kidney Dis 1999; 33(1), 73-81.
57. Patel S.R., Ke H.Q. Regulation of calcitriol receptors and its mRNA in normal and renal failure rats. Kidney Int 1994; 45: 1020-1027.
58. Pearce S.M.S., Trump D., Wooding C. et al. Calcium-sensing receptor mutations in familial benign hypercalciemia and neonatal hyperparathyroidism. J Clin Invest 1995; 96: 2683-2692.
59. Pollak M.R., Seidman C.E., Brown E.M. Three inherited disorders of calcium sensing. Medicine (Balt) 1996; 75: 115-123.
60. Portale A.A., Halloran B.P., Morris R.C. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D3 by phosphorus in normal men. J Clin Invest 1989; 83: 1494-1499.
61. Qing D.P., Ding H., Vadgama J. et al. Elevate myocardial cytosolic calcium impairs insulin-like growth factor-1 stimulated protein syntesis in CRF. J Am Soc Nephrol 1999; 10: 84-92.
62. Raine A.E.G., Bedford L., Simpson A.W.M. et al. Hyperparathyroidism, platelet intracellular free calcium and hypertension in CRF. Kidney Int 1993; 43: 700-705.
63. Ritz E., Stefanski A., Rambausek M. The role of the parathyroid glands in the uremic syndrome. Am J Kidney Dis 1995; 26(5), 808-813.
64. Russelli J. Interaction between calcium and 1,25 dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor mRNA in avian parathyroids. Endocrinology 1993; 132: 2639-2644.
65. Schleiffer R., Pernot F., Jonest R. Endothellium is a target organ of parathyroid secrecions in genetic hypertensive rats. Horm Metab Res 1995; 27: 16-18.
66. Silver J., Moallem E., Kilav R. et al. New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure. Nephrol Dial Transplant 111 1996; (suppl 3), 2-5.
67. Silver J., Naweh-Many T., Mayer H. et al. Regulation by vitamin D metabolites of parathyroid gene transcription in vivo in rat. J Clin Invest 1986; 78: 1296-1301.
68. Silver J., Russel J., Sherwood L.M. Regulation by vitamin D metabolites of mRNA for preproparathyroid hormon in isolated bovine parathyroid cells. Proc Nate Acad Sci 1985; 82: 4270-4273.
69. Slatopolsky E., Delmez J.A. Pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 1994; 23: 229-236.
70. Slatopolsky E., Finch J., Denda M. et al. Phosphorus restriction prevents parathyroid gland growth: high phosphorus directly stimulates PTH secretion in vivo. J Clin Invest 1996; 97: 2534-2540.
71. Smogorzewski M. PTH, chronic renal failure and myocardium. Miner Electrol Metab 1995; 21: 55-62.
72. Smogorzewski M., Campese V.M., Massry S.G. Abnormal norepinephrine uptake and release in brain synaptosomes in CRF. Kidney Int 1993; 44: 630-637.
73. Smogorzewski M., Koureta P., Fadda G. et al. Chronic parathyroid hormone excess in vivo increases resting levels of cytosolic calcium in brain synaptosomes: studies in the presence and absence of chronic renal failure. L Amer Soc Nephrol 1991; 1: 1162-1168.
74. Stephen G., Rostand S.G., Tilman B. Parathyroid hormone, vitamin D and cardiovascular disease in chronic renal failure. Kidney Int 1999; 56: 383-392.
75. Szabo A., Merke J., Beier E. et al. 1,25(OH)2D3 inhibits parathyroid cell proliferation in experemental uremia. Kidney Int 1989; 35: 1049-1056.
76. Szabo A., Merke J., Thommasset H., Ritz E. Eur J Clin Invest 1991; 21: 521-526.
77. Terman D.S., Alfrey A.C., Hammond W.S. et al. Cardiac calcification in uremia: a clinical, biochemical and pathological study. Am J Med 1971; 50: 744-755.
78. Thuraisingham R.C., Tucker B., Lipkin G.W. et al. Left ventricular hypertrophy in early renal failure. RA-BAPN, oct., 1993; 859.
79. Thenmin N., Smogorzewski M., Massry S.G. Derangements in acetylcholine metabolism in brain synaptosomes in CRF. Kidney Int 1993; 44: 630-637.
80. Tian J., Smogorzewski M., Kedes L., Massry S.G. PTH - PTHrP receptors mRNA in downregulated in chronic renal failure. Am J Nephrol 1994; 14: 41-46.
81. Thomas L., Clemens P.D. Cardiovascular biology of the parathyroid hormone-related proteins. Endocrinology of cardiovascular function. Ed. By Ellis R., Levin A., Terry L. Kluwer Academic Publishers. Boston (Dordrecht) London, 1998; 237-254.
82. Wang R., Karpinski E., Pang P.K. Parathyroid hormone selectively inhibits L-type calcium channels in single vascular smooth muscle cells of the rat. J Physiol 1991; 441: 325-346.
83. Wang R., Wu L., Karpinski E., Pang P.K. The changes in contractile status of single vascular smooth muscle cells and ventricular cells induced by bPTH-(1,34). Life Sci 1993; 52: 793-801.
84. Wareham N.J., Byrne C.D., Carr C. et al. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease. Metabolism 1997; 46: 1171-1177.
85. Weisinger J.R., Fafus M.J., Langman C.B. et al. Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized parathyroid hormone - replete rat. J Bone Miner Res 1989; 4: 929-935.

Другие статьи по теме

• Проблемы лечения перитонитов, осложняющих хронический перитонеальный диализ
• Молекулярная физиология почки и проблемы детской нефрологии (нарушения функций почек, хроническая почечная недостаточность)
• Спорные вопросы хирургического лечения вторичного гиперпаратиреоза. Обзор литературы
• Тубулярный транспорт кальция в почках, физиология и клиническое значение: terra «cognita»